speb/financial-data huggingface dataset:
NUCLEUS.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 3300000.00
NUCLEUS.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -273500000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Assets: 8741800000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 6106600000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Debt: 62600000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 6106600000.00
NUCLEUS.NS income_statement (annual, 2023-03-31) — Total Expenses: 4964200000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2635200000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3907500000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 305100000.00
NUCLEUS.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 4200000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 123400000.00
NUCLEUS.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 223000000.00
NUCLEUS.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 223000000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Trading Securities: 1240000000.00
NUCLEUS.NS balance_sheet (annual, 2023-03-31) — Working Capital: 2504200000.00
NUCLEUS.NS income_statement (annual, 2023-03-31) — Write Off: 4600000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — +Operating Expense: 1190200000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — +Total Revenue: 8264500000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 164600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1661600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -486400000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 56100000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -46100000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 1092900000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 26773324.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Basic EPS: 71.56
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 504900000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 281800000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -286400000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 45900000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 267700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 455000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 4009900000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -267700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 72000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 383000000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -116300000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Change In Payable: 41900000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 63400000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 710600000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -51200000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Common Stock: 267700000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -267700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 7774400000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Common Stock Payments: 0.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 80700000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 5015800000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Current Assets: 6117600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 27800000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 27800000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Current Deferred Assets: 4500000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 3300000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2953400000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 51200000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Deferred Tax: 56200000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Depreciation: 145500000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 145500000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 145500000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 145500000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 26773324.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Diluted EPS: 71.56
NUCLEUS.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1916000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2700000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 4400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — EBIT: 2563400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — EBITDA: 2708900000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 4300000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — End Cash Position: 458000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1423800000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -301600000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 1933900000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -328500000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -6700000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 198800000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 19900000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1707700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 1008300000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Gross Profit: 3248700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 340000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Interest Expense: 5400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 5400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Interest Income: 155200000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 155200000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -5400000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: -34400000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 7774400000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1969900000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 130000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 4185500000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 53200000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 18100000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 18100000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 314000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 592600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -2900000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Income: 1916000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1916000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1916000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1916000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1916000000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2558000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1916000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Interest Income: 145700000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -1660700000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 145700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Net PPE: 521900000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -279200000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 7754500000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 80300000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 33400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2378200000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Normalized Income: 1668305700.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2220300000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Operating Income: 2058500000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Operating Revenue: 8264500000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 26773324.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 423500000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 2245700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 7506700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 19900000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -149700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 88800000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 15900000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 416600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Payable: 647300000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Properties: 441200000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 234000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 3554900000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Other Special Charges: -6700000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Payables: 814600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 200600000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Pretax Income: 2558000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -286400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 5015800000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 145500000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 21800000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 21800000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: 0.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 5700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 7294700000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 7200000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 36700000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 235500000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Share Issued: 26773324.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Special Income Charges: 6700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 7774400000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 7754500000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 83005700.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Tax Provision: 642000000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 700000.00
NUCLEUS.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -774700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Assets: 11140200000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 7774400000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Debt: 45900000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 7774400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Total Expenses: 6206000000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3365800000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 5022600000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 412400000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 4100000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 3300000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 330700000.00
NUCLEUS.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 330700000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Trading Securities: 1328800000.00
NUCLEUS.NS balance_sheet (annual, 2024-03-31) — Working Capital: 3164200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 143400000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 997100000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 5868800000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 32600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 567200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 3243400000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 7164600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 58600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4657700000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 21400000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 21400000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 3759700000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 74600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 13800000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 490200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 7164600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 128600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 5868800000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 11200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 11200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 431200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 0.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 490200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 7150800000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 106900000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 26325306.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 412500000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 2983900000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 6901300000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 13800000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 89900000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 431600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 4700000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 2676200000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 145400000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 26773324.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 7164600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 7150800000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 11473600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 7164600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 32600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 7164600000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 4309000000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 6815900000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 549300000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 2000000.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 448018.00
NUCLEUS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 898000000.00
NUCLEUS.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
NUCLEUS.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
NUCLEUS.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1282600000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 352900000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8322500000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2289600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 129000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 129000000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1244300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1244300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -583700000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -583700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 60600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 60600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -900000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 3093000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 3093000000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 26548701.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 26329268.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Basic EPS: 61.40
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 24.60
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 458000000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 265800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 265800000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -152200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 20000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 20000000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 263300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 501600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 501600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3585900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3585900000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -334700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 116800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 116800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 384800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 384800000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -1200000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Change In Payable: -35600000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 337300000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 178300000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 43600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 263300000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -334700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 8142200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 8142200000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: -892100000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 82600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 82600000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 5504500000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1225800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 5443600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 5443600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 11200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 11200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 11200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 11200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Current Deferred Assets: 700000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 92500000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 92500000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2825500000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2825500000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 55600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 55600000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Deferred Tax: 46700000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Depreciation: 148100000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 148100000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 148100000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 34100000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 148100000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 34100000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 26548701.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 26329268.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 61.40
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 24.60
NUCLEUS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1630000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 647700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 2800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 2800000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 4400000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — EBIT: 2193700000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — EBIT: 877100000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — EBITDA: 2341800000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 911200000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 3000000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 504600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2184300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2184300000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -1258000000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 1357200000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -396600000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 192300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 13300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 13300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1245200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1245200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 1136600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1136600000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Gross Profit: 2818000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1063800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 328100000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 328100000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Interest Expense: 3200000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 1700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 3200000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Interest Income: 258600000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 258600000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -3200000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 24800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 8142200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8142200000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -207800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 127100000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 127100000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 5277300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 5277300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 52500000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 52500000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 8800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 8800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 8800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 8800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 403100000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 403100000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 735700000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 735700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 0.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: -892100000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 3000000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Income: 1630000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Income: 647700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1630000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 647700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1630000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 647700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1630000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 647700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1630000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 647700000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 2190500000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1630000000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 647700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Interest Income: 251100000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -1700000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -84800000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 251100000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 552900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 552900000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -152200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 8128900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 8128900000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 149900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 149900000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 26400000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 26400000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1949600000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 911200000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Normalized Income: 1338155215.70
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 647700000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1509400000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Operating Income: 1535400000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 710900000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8322500000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2289600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 26325306.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 26325306.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 449200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 449200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 2016000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2016000000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 7878900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 7878900000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 13300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 13300000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -250700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 93000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 93000000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1700000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 166200000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 439600000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 318800000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 690600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 690600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 470300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 470300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 345900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 345900000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 3084300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3084300000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Payables: 822400000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 822400000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 248600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 248600000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Pretax Income: 2190500000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 875400000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -152200000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 5504500000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1225800000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 148100000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 34100000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 26000000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 26000000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: -892100000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 11400000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 11400000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 7668900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 7668900000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 64300000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 256600000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 26325306.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 26325306.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 8142200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 8142200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 8128900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 8128900000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 100355215.70
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Tax Provision: 560500000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 227700000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 6200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 6200000.00
NUCLEUS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -393900000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 11529500000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 11529500000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 8142200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8142200000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 20000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 20000000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 8142200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8142200000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Total Expenses: 6787100000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1578700000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 3387300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3387300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 6085900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6085900000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 561800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 561800000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 4300000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 92500000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 92500000.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 392200000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
NUCLEUS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 392200000.00
NUCLEUS.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Trading Securities: 1424000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Trading Securities: 1424000000.00
NUCLEUS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2618100000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2618100000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 415900000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2177200000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 26327599.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 13.37
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1455500000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 34000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 34000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 26327599.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 13.37
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — EBIT: 485400000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 519400000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 721700000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 2400000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2400000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Income: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2400000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2400000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 519400000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 352000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 305800000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2177200000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 179600000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 381900000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 483000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1455500000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 34000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 131000000.00
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
NUCLEUS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1871400000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 464000000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2135100000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 147200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1161900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 6061400000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 26316316.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 9.99
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 78900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 422300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3722300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 8487300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1600000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1475300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 5241800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 29300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 29300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3125600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 77000000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 38300000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 38300000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 26316316.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 9.99
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — EBIT: 357400000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — EBITDA: 395700000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 28700000.00